MICHAEL RACK: Open Payments
NPI 1639194566 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 15 payments from 11 companies in 2025. Trend: 2023 $281 · 2024 $308 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Tris Pharma Inc | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: CAPLYTA, Jornay PM, FANAPT, TRINTELLIX, Auvelity, ARISTADA, REXULTI, VRAYLAR.
Industry payments across TN — which companies pay providers there.
